Digest Network Come funziona
Network
/
Società
Ve
Non verificato

Veradermics, Incorporated

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteSanità

16 comunicati stampa

Guarda tutti i comunicati
17/07/2026
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Industria
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
15/07/2026
Salute
Biotecnologia
Sanità
Medicina - Varie
Farmaceutica
Web e Social Network
Telefonia e Varie
Industria
Veradermics’ Oral VDPHL01 Delivers Positive Study ‘207’ Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306’ Readout
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
14/07/2026
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Web e Social Network
Telefonia e Varie
Industria
Eventi
Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
28/05/2026
Eventi
Web e Social Network
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Veradermics to Present at Upcoming June Investor Conferences
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
27/05/2026
Eventi
Fiere
Industria
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
14/05/2026
Eventi
Fiere
Biotecnologia
Farmaceutica
Salute
Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
12/05/2026
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
30/04/2026
Finanza
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Veradermics Announces Pricing of Upsized Public Offering and Private Placement
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
27/04/2026
Finanza
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Veradermics Announces Launch of Public Offering
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
26/04/2026
Web e Social Network
Telefonia e Varie
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0